Sutro Biopharma (STRO) Change in Receivables (2017 - 2025)

Sutro Biopharma recorded quarterly Change in Receivables of $55000.0 in Q4 2025, up 101.35% quarter-over-quarter from -$4.1 million in Q3 2025, and down 97.2% year-over-year from $2.0 million in Q4 2024.

Sutro Biopharma's Change in Receivables history runs 9 years deep, the most recent figure standing at $55000.0 for Q4 2025.

  • In Q4 2025, Change in Receivables fell 97.2% year-over-year to $55000.0; the TTM figure through Dec 2025 stood at -$4.6 million (up 83.11% YoY), while the FY2025 annual figure was -$4.6 million, up 83.11% from the prior year.
  • Change in Receivables came in at $55000.0 for Q4 2025 at Sutro Biopharma, up from -$4.1 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $86.0 million in Q2 2022 to a low of -$86.4 million in Q3 2022.
  • A 5-year average of -$79550.0 and a median of $125000.0 in 2021 frame the typical range for Change in Receivables.
  • Across the five-year window, Change in Receivables jumped 4348.27% in 2022 and plunged 19425.4% in 2024, its largest moves.
  • Sutro Biopharma's Change in Receivables stood at $124000.0 in 2021, then sank by 3429.03% to -$4.1 million in 2022, then soared by 571.2% to $19.5 million in 2023, then sank by 89.92% to $2.0 million in 2024, then tumbled by 97.2% to $55000.0 in 2025.
  • According to Business Quant data, Change in Receivables over the past three periods registered $55000.0, -$4.1 million, and -$5.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 208,524.00
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn -39.80 Mn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -1.20 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 110.42 Mn
10 Sutro Biopharma 248.39 Mn 248.39 Mn - 55,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 55,000.00
Dec 31, 2025 55,000.00
Sep 30, 2025 -4.08 Mn
Sep 30, 2025 -4.08 Mn
Jun 30, 2025 -5.56 Mn
Jun 30, 2025 -5.56 Mn
Mar 31, 2025 4.95 Mn
Mar 31, 2025 4.95 Mn
Dec 31, 2024 1.96 Mn
Dec 31, 2024 1.96 Mn
Sep 30, 2024 -295,000.00
Sep 30, 2024 -295,000.00
Jun 30, 2024 -24.35 Mn
Jun 30, 2024 -24.35 Mn
Mar 31, 2024 -4.78 Mn
Mar 31, 2024 -4.78 Mn
Dec 31, 2023 19.45 Mn
Dec 31, 2023 19.45 Mn
Sep 30, 2023 6.63 Mn
Sep 30, 2023 6.63 Mn
Jun 30, 2023 126,000.00
Jun 30, 2023 126,000.00
Mar 31, 2023 2.75 Mn
Mar 31, 2023 2.75 Mn
Dec 31, 2022 -4.13 Mn
Dec 31, 2022 -4.13 Mn
Sep 30, 2022 -86.43 Mn
Sep 30, 2022 -86.43 Mn
Jun 30, 2022 85.99 Mn
Jun 30, 2022 85.99 Mn
Mar 31, 2022 -768,000.00
Mar 31, 2022 -768,000.00
Dec 31, 2021 124,000.00
Dec 31, 2021 124,000.00
Sep 30, 2021 3.17 Mn
Sep 30, 2021 3.17 Mn
Jun 30, 2021 1.93 Mn
Jun 30, 2021 1.93 Mn
Mar 31, 2021 1.67 Mn
Mar 31, 2021 1.67 Mn
Dec 31, 2020 -1.92 Mn
Dec 31, 2020 -1.92 Mn
Sep 30, 2020 2.38 Mn
Sep 30, 2020 2.38 Mn
Jun 30, 2020 -3.98 Mn
Jun 30, 2020 -3.98 Mn
Mar 31, 2020 2.78 Mn
Mar 31, 2020 2.78 Mn
Dec 31, 2019 -1.23 Mn
Dec 31, 2019 -1.23 Mn
Sep 30, 2019 1.03 Mn
Sep 30, 2019 1.03 Mn
Jun 30, 2019 3.16 Mn
Jun 30, 2019 3.16 Mn
Mar 31, 2019 849,000.00
Mar 31, 2019 849,000.00
Dec 31, 2018 46,000.00
Dec 31, 2018 46,000.00
Sep 30, 2018 -741,000.00
Sep 30, 2018 -741,000.00
Jun 30, 2018 -971,000.00
Jun 30, 2018 -971,000.00
Mar 31, 2018 2.53 Mn
Mar 31, 2018 2.53 Mn
Dec 31, 2017 -9.23 Mn
Dec 31, 2017 -9.23 Mn